Clinical Trials Browser

Phase 3 × TP protocol × 90 days × Clear all

NCT06964568 2026-02-10

CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC

Phase 3 Recruiting

Gastrointestinal

Esophageal Neoplasms